What interval of daily pain assessment is required to reliably diagnose chronic pain in SCD? The Pain in Sickle Cell Epidemiology Study
Open Access
- 23 October 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Sickle Cell Disease
- Vol. 1 (1) , yoae011
Abstract
Objectives: Chronic pain in SCD has been defined as pain on most days over 6 months. In the landmark Pain in Sickle Cell Epidemiology Study, 60% of patients submitted 5 months of diaries (153) and >49% of diaries during all months from 1 to 4. Using the same dataset, we tested daily diary assessment over shorter intervals: 2 weeks, 1 month, 2 months, 3 months, and 4 months. We defined chronic pain as intensity rated as >0 on >50% of diary days, regardless of interval. We then calculated the sensitivity and specificity of each diary interval. Results: Among the gold-standard sample, 51.3% of patients had diary-defined chronic pain. Collection intervals of 2 months or more yielded similar chronic pain prevalences with identically high sensitivity (98.3%) and specificity (93%). Intervals of 1 month and 2 weeks yielded increasingly lower specificity (80.7%, 73.7%, respectively), but preserved sensitivity (≥96.6%). Conclusion: In the Pain in Sickle Cell Epidemiology Study, intervals of 2 months or more of daily diary collection yielded high sensitivity and specificity, compared to an interval of 5-6 months. One may reasonably diagnose chronic SCD pain using 2 months of daily diaries.Keywords
Funding Information
- National Heart, Lung, and Blood Institute
- NIH
- Virginia Basic and Translational Research Program in Sickle Cell Disease (1U54HL090516)
- Sickle Cell Disease Clinical Research Network (1U10HL083732)
This publication has 94 references indexed in Scilit:
- Sleep and fatigue among youth with sickle cell disease: A daily diary studyJournal of Behavioral Medicine, 2022
- Multimodal phenotyping and correlates of pain following hematopoietic cell transplant in children with sickle cell diseasePediatric Blood & Cancer, 2022
- Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 studyAmerican Journal of Hematology, 2022
- Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot studyAmerican Journal of Hematology, 2019
- Daily pain in adults with sickle cell disease—a different perspectiveAmerican Journal of Hematology, 2017
- Management of Sickle Cell DiseaseJAMA, 2014
- Impact of individualized pain plan on the emergency management of children with sickle cell diseasePediatric Blood & Cancer, 2014
- Forgetting, Fabricating, and TelescopingArchives of internal medicine (1960), 2002
- Assessment of painful episode frequency in sickle-cell diseaseAmerican Journal of Hematology, 1997
- Intermittent Injection vs Patient-Controlled Analgesia for Sickle Cell Crisis PainArchives of internal medicine (1960), 1991